APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bicyclic Peptide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bicyclic Peptide Market Analysis and Forecast 2026-2032

30 December 2025199 pages

Choose your research edition.

Industry ResearchBicyclic Peptide Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Bicyclic Peptide Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Bicyclic Peptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bicyclic Peptide Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Bicyclic Peptide Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Bicyclic Peptide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Bicyclic Peptide's global sales reached XX (Kg) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Creative Peptides as the global sales leader, a title it has maintained for several consecutive years. Notably, Creative Peptides's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Kg), a change of XX% from the previous year. In Europe, sales were XX (Kg), showing a year-on-year of XX%. In the US, sales were XX (Kg), a year-on-year change of XX%.

The major global manufacturers in the Bicyclic Peptide market include Creative Peptides, Genscript, JPT Peptide Technologies and Hongtide, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Bicyclic Peptide production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Bicyclic Peptide by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Bicyclic Peptide, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bicyclic Peptide, also provides the consumption of main regions and countries. Of the upcoming market potential for Bicyclic Peptide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bicyclic Peptide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bicyclic Peptide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Bicyclic Peptide sales, projected growth trends, production technology, application and end-user industry.

Bicyclic Peptide Segment by Company

Creative Peptides

Genscript

JPT Peptide Technologies

Hongtide

Bicyclic Peptide Segment by Type

Heterocyclic Bicyclic Peptides

Homocyclic Bicyclic Peptides

Bicyclic Peptide Segment by Application

Neurogenic Activity

Antibacterial

Antitumor

Other

Bicyclic Peptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bicyclic Peptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bicyclic Peptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bicyclic Peptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Bicyclic Peptide production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Bicyclic Peptide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Bicyclic Peptide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bicyclic Peptide sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bicyclic Peptide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Heterocyclic Bicyclic Peptides Major Manufacturers Table 3. Homocyclic Bicyclic Peptides Major Manufacturers Table 4. Global Bicyclic Peptide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Neurogenic Activity Major Manufacturers Table 6. Antibacterial Major Manufacturers Table 7. Antitumor Major Manufacturers Table 8. Other Major Manufacturers Table 9. Bicyclic Peptide Industry Trends Table 10. Bicyclic Peptide Industry Drivers Table 11. Bicyclic Peptide Industry Opportunities and Challenges Table 12. Bicyclic Peptide Industry Restraints Table 13. Global Bicyclic Peptide Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 14. Global Bicyclic Peptide Production by Region (2021-2026) & (Kg) Table 15. Global Bicyclic Peptide Production by Region (2027-2032) & (Kg) Table 16. Global Bicyclic Peptide Production Market Share by Region (2021-2026) Table 17. Global Bicyclic Peptide Production Market Share by Region (2027-2032) Table 18. Global Bicyclic Peptide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Bicyclic Peptide Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Bicyclic Peptide Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Bicyclic Peptide Revenue Market Share by Region (2021-2026) Table 22. Global Bicyclic Peptide Revenue Market Share by Region (2027-2032) Table 23. Global Bicyclic Peptide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Kg) Table 24. Global Bicyclic Peptide Sales by Region (2021-2026) & (Kg) Table 25. Global Bicyclic Peptide Sales by Region (2027-2032) & (Kg) Table 26. Global Bicyclic Peptide Sales Market Share by Region (2021-2026) Table 27. Global Bicyclic Peptide Sales Market Share by Region (2027-2032) Table 28. Global Bicyclic Peptide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Bicyclic Peptide Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Bicyclic Peptide Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Bicyclic Peptide Sales Market Share by Manufacturers (2021-2026) Table 32. Global Bicyclic Peptide Sales Price (US$/g) of Manufacturers (2021-2026) Table 33. Global Bicyclic Peptide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bicyclic Peptide Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Bicyclic Peptide Manufacturers, Product Type & Application Table 36. Global Bicyclic Peptide Manufacturers Commercialization Time Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Bicyclic Peptide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 39. Global Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Bicyclic Peptide Revenue Market Share by Type (2021-2026) Table 42. Global Bicyclic Peptide Revenue Market Share by Type (2027-2032) Table 43. Global Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 44. Global Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 45. Global Bicyclic Peptide Sales Market Share by Type (2021-2026) Table 46. Global Bicyclic Peptide Sales Market Share by Type (2027-2032) Table 47. Global Bicyclic Peptide Price by Type (2021-2026) & (US$/g) Table 48. Global Bicyclic Peptide Price by Type (2027-2032) & (US$/g) Table 49. Global Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Bicyclic Peptide Revenue Market Share by Application (2021-2026) Table 52. Global Bicyclic Peptide Revenue Market Share by Application (2027-2032) Table 53. Global Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 54. Global Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 55. Global Bicyclic Peptide Sales Market Share by Application (2021-2026) Table 56. Global Bicyclic Peptide Sales Market Share by Application (2027-2032) Table 57. Global Bicyclic Peptide Price by Application (2021-2026) & (US$/g) Table 58. Global Bicyclic Peptide Price by Application (2027-2032) & (US$/g) Table 59. Creative Peptides Company Information Table 60. Creative Peptides Business Overview Table 61. Creative Peptides Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 62. Creative Peptides Bicyclic Peptide Product Portfolio Table 63. Creative Peptides Recent Development Table 64. Genscript Company Information Table 65. Genscript Business Overview Table 66. Genscript Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 67. Genscript Bicyclic Peptide Product Portfolio Table 68. Genscript Recent Development Table 69. JPT Peptide Technologies Company Information Table 70. JPT Peptide Technologies Business Overview Table 71. JPT Peptide Technologies Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 72. JPT Peptide Technologies Bicyclic Peptide Product Portfolio Table 73. JPT Peptide Technologies Recent Development Table 74. Hongtide Company Information Table 75. Hongtide Business Overview Table 76. Hongtide Bicyclic Peptide Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 77. Hongtide Bicyclic Peptide Product Portfolio Table 78. Hongtide Recent Development Table 79. North America Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 80. North America Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 81. North America Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 82. North America Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 83. North America Bicyclic Peptide Sales Price by Type (2021-2026) & (US$/g) Table 84. North America Bicyclic Peptide Sales Price by Type (2027-2032) & (US$/g) Table 85. North America Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 86. North America Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 87. North America Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 88. North America Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 89. North America Bicyclic Peptide Sales Price by Application (2021-2026) & (US$/g) Table 90. North America Bicyclic Peptide Sales Price by Application (2027-2032) & (US$/g) Table 91. North America Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Bicyclic Peptide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 93. North America Bicyclic Peptide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 94. North America Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 95. North America Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 96. North America Bicyclic Peptide Sales by Country (2027-2032) & (Kg) Table 97. North America Bicyclic Peptide Sales Price by Country (2021-2026) & (US$/g) Table 98. North America Bicyclic Peptide Sales Price by Country (2027-2032) & (US$/g) Table 99. United States Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 100. Canada Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 101. Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 102. Europe Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 103. Europe Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 104. Europe Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 105. Europe Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 106. Europe Bicyclic Peptide Sales Price by Type (2021-2026) & (US$/g) Table 107. Europe Bicyclic Peptide Sales Price by Type (2027-2032) & (US$/g) Table 108. Europe Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 111. Europe Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 112. Europe Bicyclic Peptide Sales Price by Application (2021-2026) & (US$/g) Table 113. Europe Bicyclic Peptide Sales Price by Application (2027-2032) & (US$/g) Table 114. Europe Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Bicyclic Peptide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. Europe Bicyclic Peptide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. Europe Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 118. Europe Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 119. Europe Bicyclic Peptide Sales by Country (2027-2032) & (Kg) Table 120. Europe Bicyclic Peptide Sales Price by Country (2021-2026) & (US$/g) Table 121. Europe Bicyclic Peptide Sales Price by Country (2027-2032) & (US$/g) Table 122. Germany Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 123. France Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 124. U.K. Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 125. Italy Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 126. Netherlands Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 127. China Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 128. China Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 129. China Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 130. China Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 131. China Bicyclic Peptide Sales Price by Type (2021-2026) & (US$/g) Table 132. China Bicyclic Peptide Sales Price by Type (2027-2032) & (US$/g) Table 133. China Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 134. China Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 135. China Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 136. China Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 137. China Bicyclic Peptide Sales Price by Application (2021-2026) & (US$/g) Table 138. China Bicyclic Peptide Sales Price by Application (2027-2032) & (US$/g) Table 139. Asia Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 140. Asia Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 141. Asia Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 142. Asia Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 143. Asia Bicyclic Peptide Sales Price by Type (2021-2026) & (US$/g) Table 144. Asia Bicyclic Peptide Sales Price by Type (2027-2032) & (US$/g) Table 145. Asia Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 146. Asia Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 147. Asia Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 148. Asia Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 149. Asia Bicyclic Peptide Sales Price by Application (2021-2026) & (US$/g) Table 150. Asia Bicyclic Peptide Sales Price by Application (2027-2032) & (US$/g) Table 151. Asia Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 152. Asia Bicyclic Peptide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 153. Asia Bicyclic Peptide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 154. Asia Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 155. Asia Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 156. Asia Bicyclic Peptide Sales by Country (2027-2032) & (Kg) Table 157. Asia Bicyclic Peptide Sales Price by Country (2021-2026) & (US$/g) Table 158. Asia Bicyclic Peptide Sales Price by Country (2027-2032) & (US$/g) Table 159. Japan Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 160. South Korea Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 161. India Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 162. Australia Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 163. China Taiwan Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 164. Southeast Asia Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 165. SAMEA Bicyclic Peptide Revenue by Type (2021-2026) & (US$ Million) Table 166. SAMEA Bicyclic Peptide Revenue by Type (2027-2032) & (US$ Million) Table 167. SAMEA Bicyclic Peptide Sales by Type (2021-2026) & (Kg) Table 168. SAMEA Bicyclic Peptide Sales by Type (2027-2032) & (Kg) Table 169. SAMEA Bicyclic Peptide Sales Price by Type (2021-2026) & (US$/g) Table 170. SAMEA Bicyclic Peptide Sales Price by Type (2027-2032) & (US$/g) Table 171. SAMEA Bicyclic Peptide Revenue by Application (2021-2026) & (US$ Million) Table 172. SAMEA Bicyclic Peptide Revenue by Application (2027-2032) & (US$ Million) Table 173. SAMEA Bicyclic Peptide Sales by Application (2021-2026) & (Kg) Table 174. SAMEA Bicyclic Peptide Sales by Application (2027-2032) & (Kg) Table 175. SAMEA Bicyclic Peptide Sales Price by Application (2021-2026) & (US$/g) Table 176. SAMEA Bicyclic Peptide Sales Price by Application (2027-2032) & (US$/g) Table 177. SAMEA Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. SAMEA Bicyclic Peptide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. SAMEA Bicyclic Peptide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. SAMEA Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032) & (Kg) Table 181. SAMEA Bicyclic Peptide Sales by Country (2021-2026) & (Kg) Table 182. SAMEA Bicyclic Peptide Sales by Country (2027-2032) & (Kg) Table 183. SAMEA Bicyclic Peptide Sales Price by Country (2021-2026) & (US$/g) Table 184. SAMEA Bicyclic Peptide Sales Price by Country (2027-2032) & (US$/g) Table 185. Brazil Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 186. Argentina Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 187. Chile Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 188. Colombia Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 189. Peru Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 190. Saudi Arabia Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 191. Israel Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 192. UAE Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 193. Turkey Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 194. Iran Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 195. Egypt Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Bicyclic Peptide Distributors List Table 199. Bicyclic Peptide Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Bicyclic Peptide Product Image Figure 2. Global Bicyclic Peptide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicyclic Peptide Market Size Share 2021 VS 2025 VS 2032 Figure . Heterocyclic Bicyclic Peptides Image Figure 1. Homocyclic Bicyclic Peptides Image Figure 2. Global Bicyclic Peptide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bicyclic Peptide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Neurogenic Activity Image Figure 5. Antibacterial Image Figure 6. Antitumor Image Figure 7. Other Image Figure 8. Global Bicyclic Peptide Capacity, Capacity Utilization (2021-2032) & (Kg) Figure 9. Global Bicyclic Peptide Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 10. Global Bicyclic Peptide Production Market Share by Region: 2025 Versus 2032 Figure 11. Global Bicyclic Peptide Production Market Share by Region (2021-2032) Figure 12. North America Bicyclic Peptide Production Growth Rate (2021-2032) & (Kg) Figure 13. Europe Bicyclic Peptide Production Growth Rate (2021-2032) & (Kg) Figure 14. China Bicyclic Peptide Production Growth Rate (2021-2032) & (Kg) Figure 15. Japan Bicyclic Peptide Production Growth Rate (2021-2032) & (Kg) Figure 16. Global Bicyclic Peptide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Bicyclic Peptide Revenue (2021-2032) & (US$ Million) Figure 18. Global Bicyclic Peptide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Bicyclic Peptide Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Bicyclic Peptide Revenue Market Share by Region (2021-2032) Figure 21. Global Bicyclic Peptide Sales (2021-2032) & (Kg) Figure 22. Global Bicyclic Peptide Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 23. Global Bicyclic Peptide Sales Market Share by Region (2021-2032) Figure 24. North America Bicyclic Peptide Sales YoY (2021-2032) & (Kg) Figure 25. Europe Bicyclic Peptide Sales YoY (2021-2032) & (Kg) Figure 26. China Bicyclic Peptide Sales YoY (2021-2032) & (Kg) Figure 27. Asia (Excluding China) Bicyclic Peptide Sales YoY (2021-2032) & (Kg) Figure 28. South America, Middle East and Africa Bicyclic Peptide Sales YoY (2021-2032) & (Kg) Figure 29. Global Bicyclic Peptide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Bicyclic Peptide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Bicyclic Peptide Revenue Market Share by Type (2021-2032) Figure 33. Global Bicyclic Peptide Sales Market Share by Type (2021-2032) Figure 34. Global Bicyclic Peptide Revenue Market Share by Application (2021-2032) Figure 35. Global Bicyclic Peptide Sales Market Share by Application (2021-2032) Figure 36. North America Bicyclic Peptide Revenue Share by Type (2021-2032) Figure 37. North America Bicyclic Peptide Sales Share by Type (2021-2032) Figure 38. North America Bicyclic Peptide Revenue Share by Application (2021-2032) Figure 39. North America Bicyclic Peptide Sales Share by Application (2021-2032) Figure 40. North America Bicyclic Peptide Revenue Share by Country (2021-2032) Figure 41. North America Bicyclic Peptide Sales Share by Country (2021-2032) Figure 42. Europe Bicyclic Peptide Revenue Share by Type (2021-2032) Figure 43. Europe Bicyclic Peptide Sales Share by Type (2021-2032) Figure 44. Europe Bicyclic Peptide Revenue Share by Application (2021-2032) Figure 45. Europe Bicyclic Peptide Sales Share by Application (2021-2032) Figure 46. Europe Bicyclic Peptide Revenue Share by Country (2021-2032) Figure 47. Europe Bicyclic Peptide Sales Share by Country (2021-2032) Figure 48. China Bicyclic Peptide Revenue Share by Type (2021-2032) Figure 49. China Bicyclic Peptide Sales Share by Type (2021-2032) Figure 50. China Bicyclic Peptide Revenue Share by Application (2021-2032) Figure 51. China Bicyclic Peptide Sales Share by Application (2021-2032) Figure 52. Asia Bicyclic Peptide Revenue Share by Type (2021-2032) Figure 53. Asia Bicyclic Peptide Sales Share by Type (2021-2032) Figure 54. Asia Bicyclic Peptide Revenue Share by Application (2021-2032) Figure 55. Asia Bicyclic Peptide Sales Share by Application (2021-2032) Figure 56. Asia Bicyclic Peptide Revenue Share by Country (2021-2032) Figure 57. Asia Bicyclic Peptide Sales Share by Country (2021-2032) Figure 58. SAMEA Bicyclic Peptide Revenue Share by Type (2021-2032) Figure 59. SAMEA Bicyclic Peptide Sales Share by Type (2021-2032) Figure 60. SAMEA Bicyclic Peptide Revenue Share by Application (2021-2032) Figure 61. SAMEA Bicyclic Peptide Sales Share by Application (2021-2032) Figure 62. SAMEA Bicyclic Peptide Revenue Share by Country (2021-2032) Figure 63. SAMEA Bicyclic Peptide Sales Share by Country (2021-2032) Figure 64. Bicyclic Peptide Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Bicyclic Peptide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Heterocyclic Bicyclic Peptides
  • Homocyclic Bicyclic Peptides
Applications
  • Neurogenic Activity
  • Antibacterial
  • Antitumor
  • Other
Companies covered
  • Creative Peptides
  • Genscript
  • JPT Peptide Technologies
  • Hongtide

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bicyclic Peptide Market by Type
  3. 1.2.1 Global Bicyclic Peptide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Heterocyclic Bicyclic Peptides
  5. 1.2.3 Homocyclic Bicyclic Peptides
  6. 1.3 Bicyclic Peptide Market by Application
  7. 1.3.1 Global Bicyclic Peptide Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Neurogenic Activity
  9. 1.3.3 Antibacterial
  10. 1.3.4 Antitumor
  11. 1.3.5 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Bicyclic Peptide Market Dynamics
  1. 2.1 Bicyclic Peptide Industry Trends
  2. 2.2 Bicyclic Peptide Industry Drivers
  3. 2.3 Bicyclic Peptide Industry Opportunities and Challenges
  4. 2.4 Bicyclic Peptide Industry Restraints
3 Global Bicyclic Peptide Production Overview
  1. 3.1 Global Bicyclic Peptide Production Capacity (2021-2032)
  2. 3.2 Global Bicyclic Peptide Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Bicyclic Peptide Production by Region
  4. 3.3.1 Global Bicyclic Peptide Production by Region (2021-2026)
  5. 3.3.2 Global Bicyclic Peptide Production by Region (2027-2032)
  6. 3.3.3 Global Bicyclic Peptide Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Bicyclic Peptide Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Bicyclic Peptide Revenue by Region
  3. 4.2.1 Global Bicyclic Peptide Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Bicyclic Peptide Revenue by Region (2021-2026)
  5. 4.2.3 Global Bicyclic Peptide Revenue by Region (2027-2032)
  6. 4.2.4 Global Bicyclic Peptide Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Bicyclic Peptide Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Bicyclic Peptide Sales by Region
  9. 4.4.1 Global Bicyclic Peptide Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Bicyclic Peptide Sales by Region (2021-2026)
  11. 4.4.3 Global Bicyclic Peptide Sales by Region (2027-2032)
  12. 4.4.4 Global Bicyclic Peptide Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Bicyclic Peptide Revenue by Manufacturers
  2. 5.1.1 Global Bicyclic Peptide Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Bicyclic Peptide Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Bicyclic Peptide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Bicyclic Peptide Sales by Manufacturers
  6. 5.2.1 Global Bicyclic Peptide Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Bicyclic Peptide Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Bicyclic Peptide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Bicyclic Peptide Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Bicyclic Peptide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Bicyclic Peptide Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Bicyclic Peptide Manufacturers, Product Type & Application
  13. 5.7 Global Bicyclic Peptide Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Bicyclic Peptide Market CR5 and HHI
  16. 5.8.2 2025 Bicyclic Peptide Tier 1, Tier 2, and Tier 3
6 Bicyclic Peptide Market by Type
  1. 6.1 Global Bicyclic Peptide Revenue by Type
  2. 6.1.1 Global Bicyclic Peptide Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Bicyclic Peptide Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Bicyclic Peptide Sales by Type
  5. 6.2.1 Global Bicyclic Peptide Sales by Type (2021-2032) & (Kg)
  6. 6.2.2 Global Bicyclic Peptide Sales Market Share by Type (2021-2032)
  7. 6.3 Global Bicyclic Peptide Price by Type
7 Bicyclic Peptide Market by Application
  1. 7.1 Global Bicyclic Peptide Revenue by Application
  2. 7.1.1 Global Bicyclic Peptide Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Bicyclic Peptide Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Bicyclic Peptide Sales by Application
  5. 7.2.1 Global Bicyclic Peptide Sales by Application (2021-2032) & (Kg)
  6. 7.2.2 Global Bicyclic Peptide Sales Market Share by Application (2021-2032)
  7. 7.3 Global Bicyclic Peptide Price by Application
8 Company Profiles
  1. 8.1 Creative Peptides
  2. 8.1.1 Creative Peptides Company Information
  3. 8.1.2 Creative Peptides Business Overview
  4. 8.1.3 Creative Peptides Bicyclic Peptide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Creative Peptides Bicyclic Peptide Product Portfolio
  6. 8.1.5 Creative Peptides Recent Developments
  7. 8.2 Genscript
  8. 8.2.1 Genscript Company Information
  9. 8.2.2 Genscript Business Overview
  10. 8.2.3 Genscript Bicyclic Peptide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Genscript Bicyclic Peptide Product Portfolio
  12. 8.2.5 Genscript Recent Developments
  13. 8.3 JPT Peptide Technologies
  14. 8.3.1 JPT Peptide Technologies Company Information
  15. 8.3.2 JPT Peptide Technologies Business Overview
  16. 8.3.3 JPT Peptide Technologies Bicyclic Peptide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 JPT Peptide Technologies Bicyclic Peptide Product Portfolio
  18. 8.3.5 JPT Peptide Technologies Recent Developments
  19. 8.4 Hongtide
  20. 8.4.1 Hongtide Company Information
  21. 8.4.2 Hongtide Business Overview
  22. 8.4.3 Hongtide Bicyclic Peptide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 8.4.4 Hongtide Bicyclic Peptide Product Portfolio
  24. 8.4.5 Hongtide Recent Developments
9 North America
  1. 9.1 North America Bicyclic Peptide Market Size by Type
  2. 9.1.1 North America Bicyclic Peptide Revenue by Type (2021-2032)
  3. 9.1.2 North America Bicyclic Peptide Sales by Type (2021-2032)
  4. 9.1.3 North America Bicyclic Peptide Price by Type (2021-2032)
  5. 9.2 North America Bicyclic Peptide Market Size by Application
  6. 9.2.1 North America Bicyclic Peptide Revenue by Application (2021-2032)
  7. 9.2.2 North America Bicyclic Peptide Sales by Application (2021-2032)
  8. 9.2.3 North America Bicyclic Peptide Price by Application (2021-2032)
  9. 9.3 North America Bicyclic Peptide Market Size by Country
  10. 9.3.1 North America Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Bicyclic Peptide Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
10 Europe
  1. 10.1 Europe Bicyclic Peptide Market Size by Type
  2. 10.1.1 Europe Bicyclic Peptide Revenue by Type (2021-2032)
  3. 10.1.2 Europe Bicyclic Peptide Sales by Type (2021-2032)
  4. 10.1.3 Europe Bicyclic Peptide Price by Type (2021-2032)
  5. 10.2 Europe Bicyclic Peptide Market Size by Application
  6. 10.2.1 Europe Bicyclic Peptide Revenue by Application (2021-2032)
  7. 10.2.2 Europe Bicyclic Peptide Sales by Application (2021-2032)
  8. 10.2.3 Europe Bicyclic Peptide Price by Application (2021-2032)
  9. 10.3 Europe Bicyclic Peptide Market Size by Country
  10. 10.3.1 Europe Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Bicyclic Peptide Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Netherlands
11 China
  1. 11.1 China Bicyclic Peptide Market Size by Type
  2. 11.1.1 China Bicyclic Peptide Revenue by Type (2021-2032)
  3. 11.1.2 China Bicyclic Peptide Sales by Type (2021-2032)
  4. 11.1.3 China Bicyclic Peptide Price by Type (2021-2032)
  5. 11.2 China Bicyclic Peptide Market Size by Application
  6. 11.2.1 China Bicyclic Peptide Revenue by Application (2021-2032)
  7. 11.2.2 China Bicyclic Peptide Sales by Application (2021-2032)
  8. 11.2.3 China Bicyclic Peptide Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Bicyclic Peptide Market Size by Type
  2. 12.1.1 Asia Bicyclic Peptide Revenue by Type (2021-2032)
  3. 12.1.2 Asia Bicyclic Peptide Sales by Type (2021-2032)
  4. 12.1.3 Asia Bicyclic Peptide Price by Type (2021-2032)
  5. 12.2 Asia Bicyclic Peptide Market Size by Application
  6. 12.2.1 Asia Bicyclic Peptide Revenue by Application (2021-2032)
  7. 12.2.2 Asia Bicyclic Peptide Sales by Application (2021-2032)
  8. 12.2.3 Asia Bicyclic Peptide Price by Application (2021-2032)
  9. 12.3 Asia Bicyclic Peptide Market Size by Country
  10. 12.3.1 Asia Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Bicyclic Peptide Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Bicyclic Peptide Market Size by Type
  2. 13.1.1 SAMEA Bicyclic Peptide Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Bicyclic Peptide Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Bicyclic Peptide Price by Type (2021-2032)
  5. 13.2 SAMEA Bicyclic Peptide Market Size by Application
  6. 13.2.1 SAMEA Bicyclic Peptide Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Bicyclic Peptide Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Bicyclic Peptide Price by Application (2021-2032)
  9. 13.3 SAMEA Bicyclic Peptide Market Size by Country
  10. 13.3.1 SAMEA Bicyclic Peptide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Bicyclic Peptide Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Bicyclic Peptide Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Bicyclic Peptide Value Chain Analysis
  2. 14.1.1 Bicyclic Peptide Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Bicyclic Peptide Production Mode & Process
  6. 14.2 Bicyclic Peptide Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Bicyclic Peptide Distributors
  9. 14.2.3 Bicyclic Peptide Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst